title: Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
authors.affiliation: Nephrology Department, Hospital 12 de Octubre, Madrid, Spain.
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: M A
authors.initials: MA
authors.lastname: Muñoz
authors.forename: C
authors.initials: C
authors.lastname: Campo
authors.forename: A
authors.initials: A
authors.lastname: Andres
authors.forename: A
authors.initials: A
authors.lastname: Araque
authors.forename: C
authors.initials: C
authors.lastname: Alamo
authors.forename: M
authors.initials: M
authors.lastname: Praga
authors.forename: T
authors.initials: T
authors.lastname: Ortuño
authors.forename: E
authors.initials: E
authors.lastname: Hernandez
authors.forename: J L
authors.initials: JL
authors.lastname: Rodicio
mesh_terms: D000367:Age Factors; D000704:Analysis of Variance; D016572:Cyclosporine / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use; D012189:Retrospective Studies; D013256:Steroids / Q000627:therapeutic use*; D015996:Survival Rate
chemical_list: D016853:Muromonab-CD3; D013256:Steroids; D016572:Cyclosporine